ChemFeeds Site Navigation:
Journal Selection:
Search:

1) Correction: MEDI-573, Alone or in Combination with Mammalian Target of Rapamycin Inhibitors, Targets the Insulin-like Growth Factor Pathway in Sarcomas (Molecular Cancer Therapeutics) Thursday March 12th 2015


2) CTC Detection by Microfiltration and Adenoviral Imaging (Molecular Cancer Therapeutics) Thursday March 12th 2015


3) CTA Expression in HNSCC (Molecular Cancer Therapeutics) Thursday March 12th 2015


4) Improved CTC Detection Using EpCAM and MCAM in Breast Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


5) Synergistic EGFR and HER2 Blockade Enhances Radiation Effect (Molecular Cancer Therapeutics) Thursday March 12th 2015


6) Pdcd4 Enhances the Efficacy of OSI-906 in CRC (Molecular Cancer Therapeutics) Thursday March 12th 2015


7) Redox Modulation for Overcoming Gemcitabine Resistance (Molecular Cancer Therapeutics) Thursday March 12th 2015


8) Notch Activity Identifies Breast Cancer Stem Cells (Molecular Cancer Therapeutics) Thursday March 12th 2015


9) Targeting Androgen Receptor in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


10) Vemurafenib Resistance Signature in Melanoma (Molecular Cancer Therapeutics) Thursday March 12th 2015


11) Murine Ascites Enriches for Ovarian CSCs Expressing memGRP78 (Molecular Cancer Therapeutics) Thursday March 12th 2015


12) CD30 Expression in Mesothelioma (Molecular Cancer Therapeutics) Thursday March 12th 2015


13) HDAC6 Regulates Hh Signaling (Molecular Cancer Therapeutics) Thursday March 12th 2015


14) Stat5a/b Inhibition Potentiates Antiandrogen Therapy in Prostate Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


15) Oncogenic Mechanisms and Prevalence of FGFR3-BAIAP2L1 (Molecular Cancer Therapeutics) Thursday March 12th 2015


16) SYD985 Is Effective in Low HER2-Expressing Breast Cancer (Molecular Cancer Therapeutics) Thursday March 12th 2015


17) Tumor Evasion of Antibody Immunity (Molecular Cancer Therapeutics) Thursday March 12th 2015


18) Superior HER2 Targeting by Antibody Mixtures (Molecular Cancer Therapeutics) Thursday March 12th 2015


19) Protease-Activated Peptides (Molecular Cancer Therapeutics) Thursday March 12th 2015


20) AMG 232 Regresses Tumors and Enhances Chemotherapy Efficacy (Molecular Cancer Therapeutics) Thursday March 12th 2015


21) Hsp70-Bag3 as a Protein-Protein Interaction Target (Molecular Cancer Therapeutics) Thursday March 12th 2015


22) Hedgehog Pathway Inhibitors and Basal Cell Carcinoma (Molecular Cancer Therapeutics) Thursday March 12th 2015


23) Predictive Biomarkers for IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


24) Targeting Wee-1 Kinase in mutp53 HNSCC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


25) BRG1 Bromodomain Radiosensitizes Tumor Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


26) Metformin Inhibits Rac1 GTPase and Cancer Cell Migration (Molecular Cancer Therapeutics) Tuesday February 10th 2015


27) Role of TDP1 and TOP1 in Colorectal Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


28) GSK3{beta} Sustains Glioblastoma Invasion (Molecular Cancer Therapeutics) Tuesday February 10th 2015


29) CD147 Promotes Radioresistance in HCC Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


30) Sequential Anti-EGFR Therapy in Lung Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


31) Onartuzumab and Erlotinib Inhibits EGFR-Mutated NSCLC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


32) Stromal HA Elevation Limits mAb-Mediated Cancer Therapy (Molecular Cancer Therapeutics) Tuesday February 10th 2015


33) Sunitinib Dose Escalation Overcomes Drug Resistance (Molecular Cancer Therapeutics) Tuesday February 10th 2015


34) Tumor-Suppressor Role of Notch3 in MTC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


35) Targeted Lung Cancer Therapy with SapC-DOPS (Molecular Cancer Therapeutics) Tuesday February 10th 2015


36) Identification of a Novel CXCR4 Antagonist for Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


37) Structure-Based Design of Novel Antiangiogenic Biologics (Molecular Cancer Therapeutics) Tuesday February 10th 2015


38) Pazopanib/Paclitaxel Combination in Advanced Solid Tumors (Molecular Cancer Therapeutics) Tuesday February 10th 2015


39) PDT Targeting Tumor-Associated Macrophages (Molecular Cancer Therapeutics) Tuesday February 10th 2015


40) ALA Derivatives in the Treatment of Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


41) PI3K/mTOR Inhibition Radiosensitizes NPC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


42) Targeting Tumor-Propagating Cells in Human Glioblastoma (Molecular Cancer Therapeutics) Tuesday February 10th 2015


43) Preclinical Studies of Anti-Pancreatic Tumor Agent SKLB261 (Molecular Cancer Therapeutics) Tuesday February 10th 2015


44) Inhibition of mTORC1 and mTORC2 in Sarcoma (Molecular Cancer Therapeutics) Tuesday February 10th 2015


45) SAR125844, a Selective Intravenous MET Kinase Inhibitor (Molecular Cancer Therapeutics) Tuesday February 10th 2015


46) AMG 925 Overcomes FLT3 Inhibitor Resistance (Molecular Cancer Therapeutics) Tuesday February 10th 2015


47) Efficacy of AZD1480 against JAK-Mutated ALL (Molecular Cancer Therapeutics) Tuesday February 10th 2015


48) Berberine Induces Senescence of Glioma Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


49) NK150460: A Potential Antitumor Drug Activating AhR (Molecular Cancer Therapeutics) Tuesday February 10th 2015


50) High-Throughput Drug Screening for Novel Radiosensitizers (Molecular Cancer Therapeutics) Tuesday February 10th 2015


51) Efficacy of TAK-733 in Melanoma (Molecular Cancer Therapeutics) Tuesday February 10th 2015


52) BAI1 and Nestin in Breast Cancer Brain Metastases (Molecular Cancer Therapeutics) Wednesday January 14th 2015


53) Kinase Inhibitor Responses in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


54) JAGGED2 Promotes Pancreatic Cancer Cell Migration (Molecular Cancer Therapeutics) Wednesday January 14th 2015


55) MET Amplification in Human and Murine Prostate Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


56) ANRIL Promotes Proliferation in NSCLC (Molecular Cancer Therapeutics) Wednesday January 14th 2015


57) Lack of NPP7 Enhances Colonic Tumorigenesis (Molecular Cancer Therapeutics) Wednesday January 14th 2015


58) LIM Kinases in Prostate Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


59) Human Nucleoside Transporter Inhibition by Kinase Inhibitors (Molecular Cancer Therapeutics) Wednesday January 14th 2015


60) {Delta}NP63{alpha}-Dependent CSC Behavior Is Regulated through CXCR4 (Molecular Cancer Therapeutics) Wednesday January 14th 2015


61) Inhibition of Neuroblastoma Development by Targeting Midkine (Molecular Cancer Therapeutics) Wednesday January 14th 2015


62) Arsenic Trioxide Directly Inhibits AMPK (Molecular Cancer Therapeutics) Wednesday January 14th 2015


63) Resistance to Cabazitaxel (Molecular Cancer Therapeutics) Wednesday January 14th 2015


64) SRT1720 Induces Lysosomal-Dependent Cell Death (Molecular Cancer Therapeutics) Wednesday January 14th 2015


65) Targeting CDKN1A/TP53 in Bladder Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


66) Preclinical Pharmacokinetics and Safety of Metuzumab (Molecular Cancer Therapeutics) Wednesday January 14th 2015


67) Diffusion of Bicyclic Peptides into Tumors (Molecular Cancer Therapeutics) Wednesday January 14th 2015


68) NIR-PIT for Disseminated Peritoneal Ovarian Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


69) Peptide-mAb Con{#x0237}ugate Crosses the Blood-Brain Barrier (Molecular Cancer Therapeutics) Wednesday January 14th 2015


70) iRGD Inhibits Metastasis and Repels Tumor Cells (Molecular Cancer Therapeutics) Wednesday January 14th 2015


71) Novel TMZ Analogues Overcome GBM Resistance (Molecular Cancer Therapeutics) Wednesday January 14th 2015


72) Combination of Axitinib and Crizotinib in Human Renal Cell Carcinoma (Molecular Cancer Therapeutics) Wednesday January 14th 2015


73) PP2A Inhibition Sensitizes Ovarian Cancer Cells to Cisplatin (Molecular Cancer Therapeutics) Wednesday January 14th 2015


74) YM155 Induces Apoptosis via DR5 in Pancreatic Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


75) Radioprotection of Brain Structure and Function by Porphyrin (Molecular Cancer Therapeutics) Wednesday January 14th 2015


76) Preclinical Evaluation of VT-464 in Prostate Cancer Models (Molecular Cancer Therapeutics) Wednesday January 14th 2015


77) AZD8186 Inhibits PI3K{beta}-Dependent Tumor Growth (Molecular Cancer Therapeutics) Wednesday January 14th 2015


78) MEK and PI3K Inhibition in Pancreatic Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


79) Preclinical Profile of Choline Kinase Alpha Inhibitors (Molecular Cancer Therapeutics) Wednesday January 14th 2015


80) Darinaparsin Kills Prostate Cancer Cells by Inhibiting Shh Signaling (Molecular Cancer Therapeutics) Wednesday January 14th 2015


81) Preclinical Characterization of HSP90{alpha}/{beta} Inhibitor TAS-116 (Molecular Cancer Therapeutics) Wednesday January 14th 2015


82) Repurposing Mebendazole as a Hedgehog Inhibitor (Molecular Cancer Therapeutics) Wednesday January 14th 2015


83) Acknowledgment to Reviewers (Molecular Cancer Therapeutics) Thursday December 4th 2014


84) Targeted Drug Discovery with TCGA, CMap, and CCLE (Molecular Cancer Therapeutics) Thursday December 4th 2014


85) Mouse Model of Human Lymphoma Therapy Heterogeneity (Molecular Cancer Therapeutics) Thursday December 4th 2014


86) BRAFV600E Blood Test (Molecular Cancer Therapeutics) Thursday December 4th 2014


87) Combinatorial Targeting of Notch1 and Ras/MAPK in Breast Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


88) miR-185 Is a Potential Target for TNBC Therapy (Molecular Cancer Therapeutics) Thursday December 4th 2014


89) Outcomes of Phase I Trials in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


90) Role of miR24 in Nasopharyngeal Carcinoma (Molecular Cancer Therapeutics) Thursday December 4th 2014


91) miR141-CXCL1-CXCR2 Recruits Tregs in MPE (Molecular Cancer Therapeutics) Thursday December 4th 2014


92) miR200c Induces MDR and Metastasis (Molecular Cancer Therapeutics) Thursday December 4th 2014


93) Akt-Activated Endothelium and Bevacizumab in Ovarian Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


94) Doxycycline and Hepatocellular Carcinoma (Molecular Cancer Therapeutics) Thursday December 4th 2014


95) MEK1 Gene Mutation and Gastric Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


96) PTENP1 as ceRNA in ccRCC (Molecular Cancer Therapeutics) Thursday December 4th 2014


97) ADAM9 in Gastric Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


98) Cellular Role of A687V EZH2 in ALL (Molecular Cancer Therapeutics) Thursday December 4th 2014


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

Synthesis of Functionalized Phenols

Chemical Safety & Hazard Investigation Board Chairman Steps Down

Dow Chlorine Business Will Go To Olin

Cells Can Ferry Drugs In Disk-Shaped Packs

Colorblind Chemistry offering advice

ROBOT At the American Chemical Society national meeting in...

Biopolymer Derived From Crustaceans Could Combat Military Mortalities

Wow, Lufthansa has some intense tests

DuPont CEO Kullman Seeks To Fend Off Activist Trian

Middle School Students’ ‘Bee Aware’ Campaign Lands At White House Science Fair

The Disney Periodic Table: Clever Hook or Abomination?

Yes, it was the kitty litter

Taking Your Doses For You

Do you like good music?

Editor quits journal over pay-for-expedited peer-review offer


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()